Skip to main content
Livermore
Livermore
ZHEN

US Bancorp

SEC CIK
0000036104
Latest filing
Aug 12, 2026

TVTX holding history

Travere Therapeutics, Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TVTX overviewAll 13F holders of TVTXFull Q2 2026 holdings

Shares (Q2 2026)
927
Value
$52.7K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of TVTX by US Bancorp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026927$52.7K<0.1%+12+1.3%AddedHolders
Q1 2026915$27.2K<0.1%+27+3.0%AddedHolders
Q4 2025888$33.9K<0.1%+212+31.4%AddedHolders
Q3 2025676$16.2K<0.1%−28,320−97.7%ReducedHolders
Q2 202528,996$429.1K<0.1%−2,806−8.8%ReducedHolders
Q1 202531,802$569.9K<0.1%+70.0%AddedHolders
Q4 202431,795$553.9K<0.1%+24,286+323.4%AddedHolders
Q3 20247,509$105.0K<0.1%−100−1.3%ReducedHolders
Q2 20247,609$62.5K<0.1%+6,691+728.9%AddedHolders
Q1 2024918$7.08K<0.1%+303+49.3%AddedHolders
Q4 2023615$5.53K<0.1%+541+731.1%AddedHolders
Q3 202374$662<0.1%00.0%UnchangedHolders
Q2 202374$1.14K<0.1%−294−79.9%ReducedHolders
Q1 2023368$8.28K<0.1%+294+397.3%AddedHolders
Q4 202274$1.56K<0.1%−33−30.8%ReducedHolders
Q3 2022107$3.00K<0.1%+6+5.9%AddedHolders
Q2 2022101$2.00K<0.1%−1,386−93.2%ReducedHolders
Q1 20221,487$38.0K<0.1%+1,386+1,372.3%AddedHolders
Q4 2021101$3.00K<0.1%00.0%UnchangedHolders
Q3 2021101$2.00K<0.1%−26−20.5%ReducedHolders
Q2 2021127$2.00K<0.1%+26+25.7%AddedHolders
Q1 2021101$3.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.